Clinical Trials are Getting More Diverse Thanks to AI—and Humans
Applied Clinical Trials Online It’s widely agreed that clinical trial participants should reflect the populations of people who will ultimately be affected by the resulting treatments. For instance, there’s no debate that since Hidradenitis Suppurativa (HS) is a condition most prominent among Black women, that trial populations for HS treatments should be proportionately populated by […]
read more
Evolving toward empowerment: how we are deepening relationships with patients
Applied Clinical Trials Online Multilayered strategies such as working with patient advocacy organizations and leveraging technology can help industry better partner with patients. atients are more than participants; they are partners in clinical research. As clinical research evolves, so does the way we regard this relationship. Today, global regulatory pressures combined with ethical imperatives are […]
read more
Reducing clinical and staff burnout with AI automation
Med City News As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers. Burnout among clinicians and staff remains a significant issue in healthcare, with widespread implications for patient care, staff retention, and the financial health of healthcare organizations. According to recent survey data from the American Medical Association, nearly half of […]
read more
FDA finalizes decentralized clinical trial guidance
Applied Clinical Trials Online The FDA’s guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas. Decentralized clinical trials (DCTs) are clinical trials in which some or all trial-related activities occur at locations other […]
read more